The Longevity Shift: strategic implications of the longevity medicine revolution
The Longevity Shift: strategic implications of the longevity medicine revolution

The Longevity Shift: Strategic implications of the longevity medicine revolution

Turn longevity from trend to strategy: where should pharma play - and how to win?

Longevity is emerging as one of the most dynamic frontiers in healthcare innovation. In 2025, longevity’s not just about living longer; it’s about preserving vitality, function and independence - creating new strategic options for portfolios and go to market.

Explore the strategic implications of the longevity market revolution:

  • Navigate five strategic categories, including GLP-1s
  • Map assets to longevity-relevant opportunities
  • Plan for regional regulatory pathways and access implications
  • Distinguish consumer activation models by market 

This new point of view maps the emergence of longevity medicine, the strategic implications and the growing recognition that longevity may become a defining theme in the future of medicine.
 

The author(s)

Related news